Willow Biosciences Inc.
WLLW.TO
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.67% | 66.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.67% | 66.52% | |||
| Cost of Revenue | -269.00% | 15.82% | |||
| Gross Profit | 2,043.81% | 239.17% | |||
| SG&A Expenses | -15.08% | 12.51% | |||
| Depreciation & Amortization | 13.90% | -10.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.63% | 10.84% | |||
| Operating Income | 38.29% | 28.67% | |||
| Income Before Tax | -12.84% | 27.55% | |||
| Income Tax Expenses | -309.01% | -12.89% | |||
| Earnings from Continuing Operations | 29.78% | 25.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.78% | 25.91% | |||
| EBIT | 38.29% | 28.67% | |||
| EBITDA | 68.33% | 29.84% | |||
| EPS Basic | 30.77% | 32.99% | |||
| Normalized Basic EPS | -11.43% | 35.19% | |||
| EPS Diluted | 30.77% | 32.99% | |||
| Normalized Diluted EPS | -11.43% | 35.19% | |||
| Average Basic Shares Outstanding | 0.85% | 10.91% | |||
| Average Diluted Shares Outstanding | 0.85% | 10.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||